Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001213900-26-077193
Filing Date
2026-07-10
Accepted
2026-07-10 16:46:40
Documents
15
Effectiveness Date
2026-07-10

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT ea0297617-s8_longeveron.htm S-8 45628
2 OPINION OF BUCHANAN INGERSOLL & ROONEY PC ea029761701ex5-1.htm EX-5.1 13810
3 CONSENT OF CBIZ CPAS P.C., INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM ea029761701ex23-1.htm EX-23.1 1464
4 CONSENT OF MARCUM LLP, FORMER INDEPENDENT REGISTERED ACCOUNTING FIRM ea029761701ex23-2.htm EX-23.2 1545
5 FILING FEE TABLE ea029761701ex-fee.htm   iXBRL EX-FILING FEES 16433
6 GRAPHIC ea029761701_ex5-1img1.jpg GRAPHIC 9548
  Complete submission text file 0001213900-26-077193.txt   212919

Data Files

Seq Description Document Type Size
18 EXTRACTED XBRL INSTANCE DOCUMENT ea029761701ex-fee_htm.xml XML 5150
Mailing Address 1951 NW 7TH AVENUE SUITE 520 MIAMI FL 33136
Business Address 1951 NW 7TH AVENUE SUITE 520 MIAMI FL 33136 305-302-7158
Longeveron Inc. (Filer) CIK: 0001721484 (see all company filings)

EIN.: 472174146 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-297388 | Film No.: 261169222
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)